The plant must build up this gradient across the cell membranes, and this costs energy. Further experiments showed that the ...
A study in Nature applies structure-based drug design to develop covalent inhibitors that selectively target an oncogenic AKT1 mutant and avoid the dose-limiting toxicities of pan-AKT inhibitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback